Upexi (NASDAQ:UPXI) Rating Increased to Overweight at Cantor Fitzgerald

Cantor Fitzgerald upgraded shares of Upexi (NASDAQ:UPXI) from a neutral rating to an overweight rating in a research note published on Monday morning, Marketbeat reports. The firm currently has $16.00 target price on the stock.

Separately, Wall Street Zen upgraded shares of Upexi to a “hold” rating in a research note on Friday, May 30th.

Upexi Trading Down 1.7%

Shares of NASDAQ:UPXI opened at $9.84 on Monday. The firm’s 50 day moving average price is $9.66 and its 200-day moving average price is $5.67. Upexi has a twelve month low of $1.90 and a twelve month high of $22.57. The company has a current ratio of 0.58, a quick ratio of 0.53 and a debt-to-equity ratio of 0.35.

Upexi (NASDAQ:UPXI) last issued its quarterly earnings data on Friday, May 16th. The company reported ($2.87) earnings per share for the quarter. The firm had revenue of $3.16 million for the quarter.

Insiders Place Their Bets

In other news, CFO Andrew James Norstrud bought 43,860 shares of the firm’s stock in a transaction on Thursday, April 17th. The shares were bought at an average price of $2.28 per share, for a total transaction of $100,000.80. Following the purchase, the chief financial officer now owns 59,138 shares in the company, valued at approximately $134,834.64. The trade was a 287.08% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gene Salkind bought 241,229 shares of the firm’s stock in a transaction on Thursday, April 17th. The shares were purchased at an average price of $2.28 per share, for a total transaction of $550,002.12. Following the purchase, the director now owns 365,127 shares in the company, valued at $832,489.56. This trade represents a 194.70% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 942,984 shares of company stock worth $2,150,004. Company insiders own 31.60% of the company’s stock.

Institutional Investors Weigh In On Upexi

An institutional investor recently bought a new position in Upexi stock. Bank of Montreal Can bought a new position in shares of Upexi, Inc. (NASDAQ:UPXI) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 10,008 shares of the company’s stock, valued at approximately $36,000. Bank of Montreal Can owned 0.81% of Upexi at the end of the most recent quarter. 5.68% of the stock is owned by institutional investors.

About Upexi

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.